Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome

Open access
Vermeer, Maarten H., van Doorn, Remco, Dijkman, Remco, Mao, Xin, Whittaker, Sean, van Voorst Vader, Pieter C., Gerritsen, Marie-Jeanne P., Geerts, Marie-Louise, Gellrich, Sylke, Söderberg, Ola, Leuchowius, Karl-Johan, Landegren, Ulf, Out-Luiting, Jacoba J., Knijnenburg, Jeroen, IJszenga, Marije, Szuhai, Karoly, Willemze, Rein, Tensen, Cornelis P.·2008·Cancer Research

Abstract

This study was designed to identify highly recurrent genetic alterations typical of Sézary syndrome (Sz), an aggressive cutaneous T-cell lymphoma/leukemia, possibly revealing pathogenetic mechanisms and novel therapeutic targets. High-resolution array-based comparative genomic hybridization was done on malignant T cells from 20 patients. Expression levels of selected biologically relevant genes residing within loci with frequent copy number alteration were measured using quantitative PCR. Combined binary ratio labeling-fluorescence in situ hybridization karyotyping was done on malignant cells from five patients. Minimal common regions with copy number alteration occurring in at least 35% of patients harbored 15 bona fide oncogenes and 3 tumor suppressor genes. Based on the function of the identified oncogenes and tumor suppressor genes, at least three molecular mechanisms are relevant in the pathogenesis of Sz. First, gain of cMYC and loss of cMYC antagonists (MXI1 and MNT) were observed in 75% and 40% to 55% of patients, respectively, which were frequently associated with deregulated gene expression. The presence of cMYC/MAX protein heterodimers in Sézary cells was confirmed using a proximity ligation assay. Second, a region containing TP53 and genome maintenance genes (RPA1/HIC1) was lost in the majority of patients. Third, the interleukin 2 (IL-2) pathway was affected by gain of STAT3/STAT5 and IL-2 (receptor) genes in 75% and 30%, respectively, and loss of TCF8 and DUSP5 in at least 45% of patients. In sum, the Sz genome is characterized by gross chromosomal instability with highly recurrent gains and losses. Prominent among deregulated genes are those encoding cMYC, cMYC-regulating proteins, mediators of MYC-induced apoptosis, and IL-2 signaling pathway components. [Cancer Res 2008;68(8):2689–98]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-07-6398

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 197

Metadata

Authors
Vermeer, M. H., van Doorn, R., Dijkman, R., Mao, X., Whittaker, S., van Voorst Vader, P. C., Gerritsen, M.-J. P., Geerts, M.-L., Gellrich, S., Söderberg, O., Leuchowius, K.-J., Landegren, U., Out-Luiting, J. J., Knijnenburg, J., IJszenga, M., Szuhai, K., Willemze, R., & Tensen, C. P.
Venue
Cancer Research
Published
2008-04-15
Volume
68
Issue
8
Pages
2689-2698
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2138864086
Cited by
197
References
2
FWCI
16.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-6398
The paper
Vermeer, M. H., van Doorn, R., Dijkman, R., Mao, X., Whittaker, S., van Voorst Vader, P. C., Gerritsen, M.-J. P., Geerts, M.-L., Gellrich, S., Söderberg, O., Leuchowius, K.-J., Landegren, U., Out-Luiting, J. J., Knijnenburg, J., IJszenga, M., Szuhai, K., Willemze, R., & Tensen, C. P. (2008). Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-6398

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.